Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Sales | 1,501 | 1,659 | 1,824 | 1,777 | 1,580 |
Cost of Goods | 1,149 | 1,099 | 1,263 | 1,202 | 1,286 |
Gross Profit | 352 | 560 | 561 | 575 | 294 |
Operating Expenses | 23,394 | 20,954 | 18,830 | 29,306 | 14,140 |
Operating Income | -22,893 | -20,295 | -18,006 | -28,529 | -13,560 |
Other Income | 89 | -851 | -155 | -225 | -219 |
Pre-tax Income | -22,804 | -21,146 | -18,161 | -28,754 | -13,779 |
Net Income Continuous | -22,804 | -21,146 | -18,161 | -28,754 | -13,597 |
Net Income Discontinuous | N/A | N/A | N/A | N/A | 424 |
Net Income | $-22,804 | $-21,146 | $-18,161 | $-28,754 | $-13,173 |
EPS Basic Total Ops | -0.34 | -0.35 | -0.34 | -0.57 | -0.30 |
EPS Basic Continuous Ops | -0.35 | -0.35 | -0.34 | -0.57 | -0.31 |
EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
EPS Diluted Total Ops | -0.34 | -0.35 | -0.34 | -0.57 | -0.30 |
EPS Diluted Continuous Ops | -0.35 | -0.35 | -0.34 | -0.57 | -0.31 |
EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | 0.01 |
EBITDA(a) | $-22,696 | $-20,104 | $-17,759 | $-28,241 | $-14,009 |